Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED)
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This is a randomized, two-way crossover, multicenter study evaluating the consumer preference
of Phenylephrine Extended Release Tablets, 30 mg to be taken as one tablet every 12 hours, or
Phenylephrine Immediate Release Tablets, 10 mg to be taken as one tablet every 4 hours in
subjects with at least mild allergic rhinitis and nasal congestion. Approximately 250
participants will complete a questionnaire after taking one test product for 3 days followed
by a 3 day (± 1 day) washout period; and then taking the alternate test product for 3 days.
Analysis of which product the consumer preferred, if any, and which product was more
convenient, if any, will be evaluated.